UB Paderborn / Katalog / Suche / in CDI

1187PD - Phase II study of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis

Annals of oncology, 2019-10, Vol.30, p.v483-v484

2019

Volltextzugriff (PDF)

994O - Lenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC)

Annals of oncology, 2019-10, Vol.30, p.v404-v405

2019

Volltextzugriff (PDF)

Lenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC)

Annals of oncology, 2019-10, Vol.30, p.v404-v405

2019

Volltextzugriff (PDF)

Phase II study of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis

Annals of oncology, 2019-10, Vol.30, p.v483-v484

2019

Volltextzugriff (PDF)

A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma

Annals of oncology, 2017-09, Vol.28, p.v295-v296

2017

Volltextzugriff (PDF)

Epacadostat plus pembrolizumab in patients with advanced melanoma: Phase 1 and 2 efficacy and safety results from ECHO-202/KEYNOTE-037

Annals of oncology, 2017-09, Vol.28, p.v428-v429

2017

Volltextzugriff (PDF)

Efficacy results of selective AXL inhibitor bemcentinib with pembrolizumab following chemo in patients with NSCLC

Annals of oncology, 2019-10, Vol.30, p.v649-v650

2019

Volltextzugriff (PDF)

1576P - Efficacy results of selective AXL inhibitor bemcentinib with pembrolizumab following chemo in patients with NSCLC

Annals of oncology, 2019-10, Vol.30, p.v649-v650

2019

Volltextzugriff (PDF)

Phase 2 study of pembrolizumab alone or combined with acalabrutinib in platinum-refractory metastatic urothelial carcinoma (mUC)

Annals of oncology, 2017-09, Vol.28, p.v303-v304

2017

Volltextzugriff (PDF)

First in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1

Annals of oncology, 2018-10, Vol.29, p.viii404-viii404

2018

Volltextzugriff (PDF)

Phase Ib/II study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who had progressive disease on or after prior anti-PD-1 therapy

Annals of oncology, 2018-10, Vol.29, p.viii451-viii452

2018

Volltextzugriff (PDF)

Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii732-viii732

2018

Volltextzugriff (PDF)

LOW-TEMPERATURE NMR STUDY OF THE SEMICONDUCTOR MINERAL CuFe[S.sub.2]

Journal of applied spectroscopy, 2016-11, Vol.83 (5), p.771

2016

Volltextzugriff (PDF)

Investigation of the Temperature Dependence of the NQR Parameters in Covellite

Materials science forum, 2016-03, Vol.845, p.69-72

2016

Volltextzugriff (PDF)

Electron-density distribution in CuFe[S.sub.2] as determined by [sup.63,65]Cu NMR in an internal magnetic field

Journal of applied spectroscopy, 2013-07, Vol.80 (3), p.351

2013

Volltextzugriff (PDF)

Complex role of mannose-binding lectin in infectious diseases

The Journal of pediatrics, 2009-08, Vol.155 (2), p.301-301

2009

Volltextzugriff (PDF)

DDR-Strafvollzugsinhalte und -ziele, Einstellungen weiblicher Strafgefangener zu Gesellschaft, Staat und Politik in den alten und neuen Ländern der Bundesrepublik Deutschland: Textkritische Analyse und empirische Gegenüberstellung

Vogel, Christian

1998

Volltextzugriff (PDF)

Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance

Radiation research, 1994-11, Vol.140 (2), p.180

1994

Volltextzugriff (PDF)

Transgenic Mice Bearing the Human c-myc Gene Activated by an Immunoglobulin Enhancer: A Pre-B-Cell Lymphoma Model

Proceedings of the National Academy of Sciences - PNAS, 1988-08, Vol.85 (16), p.6047-6051

1988

Volltextzugriff (PDF)

2196 Cyclin D1 overexpression modulates radiation-induced G1 arrest and apoptosis

International journal of radiation oncology, biology, physics, 1996, Vol.36 (1), p.372-372

1996

Volltextzugriff (PDF)

Hepatocyte Growth Factor Regulates Transforming Growth Factor α in HepG2 Hepatic Cells

Biochemical and biophysical research communications, 1994-04, Vol.200 (2), p.1099-1104

1994

Volltextzugriff (PDF)

Transdominant negative mutations in p53 do not always result in altered radiation sensitivity and metastatic potential

International journal of radiation oncology, biology, physics, 1993, Vol.27, p.212-212

1993

Volltextzugriff (PDF)

Elevated PCNA expression in pituitary adenomas failing definitive radiation therapy

International journal of radiation oncology, biology, physics, 1993, Vol.27, p.205-205

1993

Volltextzugriff (PDF)

Enhanced survival of transgenic hepatocytes expressing hepatocyte growth factor in hepatocyte tissue engineering

Transplantation proceedings, 1997-02, Vol.29 (1), p.858-860

1997

Volltextzugriff (PDF)

Significance of hepatocyte growth factor (HGF) in liver regeneration: From basic and clinical points of view

Hepatology (Baltimore, Md.), 1994-04, Vol.19 (4), p.I123-I123

1994

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

1187PD - Phase II study of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis

994O - Lenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC)

Lenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC)

Phase II study of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis

A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma

Epacadostat plus pembrolizumab in patients with advanced melanoma: Phase 1 and 2 efficacy and safety results from ECHO-202/KEYNOTE-037

Efficacy results of selective AXL inhibitor bemcentinib with pembrolizumab following chemo in patients with NSCLC

1576P - Efficacy results of selective AXL inhibitor bemcentinib with pembrolizumab following chemo in patients with NSCLC

Phase 2 study of pembrolizumab alone or combined with acalabrutinib in platinum-refractory metastatic urothelial carcinoma (mUC)

First in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1

Phase Ib/II study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who had progressive disease on or after prior anti-PD-1 therapy

Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

LOW-TEMPERATURE NMR STUDY OF THE SEMICONDUCTOR MINERAL CuFe[S.sub.2]

Investigation of the Temperature Dependence of the NQR Parameters in Covellite

Electron-density distribution in CuFe[S.sub.2] as determined by [sup.63,65]Cu NMR in an internal magnetic field

Complex role of mannose-binding lectin in infectious diseases

DDR-Strafvollzugsinhalte und -ziele, Einstellungen weiblicher Strafgefangener zu Gesellschaft, Staat und Politik in den alten und neuen Ländern der Bundesrepublik Deutschland: Textkritische Analyse und empirische Gegenüberstellung

Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance

Transgenic Mice Bearing the Human c-myc Gene Activated by an Immunoglobulin Enhancer: A Pre-B-Cell Lymphoma Model

2196 Cyclin D1 overexpression modulates radiation-induced G1 arrest and apoptosis

Hepatocyte Growth Factor Regulates Transforming Growth Factor α in HepG2 Hepatic Cells

Transdominant negative mutations in p53 do not always result in altered radiation sensitivity and metastatic potential

Elevated PCNA expression in pituitary adenomas failing definitive radiation therapy

Enhanced survival of transgenic hepatocytes expressing hepatocyte growth factor in hepatocyte tissue engineering

Significance of hepatocyte growth factor (HGF) in liver regeneration: From basic and clinical points of view

Suchergebnisse filtern